Your browser doesn't support javascript.
loading
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status.
Bazarbachi, Ali; Labopin, Myriam; Kharfan-Dabaja, Mohamed A; Schwerdtfeger, Rainer; Volin, Liisa; Bourhis, Jean Henri; Socié, Gérard; Daguindau, Etienne; Gedde-Dahl, Tobias; Rambaldi, Alessandro; Karas, Michal; Schlimok, Günter; Blaise, Didier; Chevallier, Patrice; Malard, Florent; Schmid, Christoph; Esteve, Jordi; Nagler, Arnon; Mohty, Mohamad.
Afiliación
  • Bazarbachi A; Department of Internal Medicine, Bone Marrow Transplantation Program, American University of Beirut Medical Center, Beirut bazarbac@aub.edu.lb.
  • Labopin M; EBMT Paris study office / CEREST-TC, France Department of Hematology, Saint Antoine Hospital, Paris, France INSERM UMR 938, Paris, France Université Pierre et Marie Curie, Paris, France.
  • Kharfan-Dabaja MA; Department of Internal Medicine, Bone Marrow Transplantation Program, American University of Beirut Medical Center, Beirut Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center/University of South Florida College of Medicine, Tampa, Florida.
  • Schwerdtfeger R; Deutsche Klinik für Diagnostik KMT Zentrum, Wiesbaden, Germany.
  • Volin L; Department of Medicine, Helsinki, Finland.
  • Bourhis JH; Gustave Roussy, institut de cancérologie, BMT Service, Division of Hematology, Department of Medical Oncology, Villejuif, France.
  • Socié G; Hopital St. Louis, Dept.of Hematology - BMT, Paris, France.
  • Daguindau E; Hopital Jean Minjoz, Service d' Hématologie, Besancon, France.
  • Gedde-Dahl T; Rikshospitalet Department of Medicine, The National Hospital, Oslo, Norway.
  • Rambaldi A; Azienda Ospedaliera Papa Giovanni XXIII Hematology and Bone Marrow Transplant Unit, Bergamo, Italy.
  • Karas M; Charles University Hospital, Dept. of Hematology/Oncology, Pilsen, Czech Republic.
  • Schlimok G; Klinikum Augsburg II Medizinische Klinik, Augsburg, Germany.
  • Blaise D; Programme de Transplantation & Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France.
  • Chevallier P; CHU Nantes Dept. D'Hématologie, Nantes, France;
  • Malard F; EBMT Paris study office / CEREST-TC, France Department of Hematology, Saint Antoine Hospital, Paris, France INSERM UMR 938, Paris, France Université Pierre et Marie Curie, Paris, France.
  • Schmid C; SCT Unit, Klinikum Augsburg, Germany;
  • Esteve J; Department of Hematology, Hospital Clinic, IDIBAPS, Barcelona, Spain.
  • Nagler A; EBMT Paris study office / CEREST-TC, France Tel Aviv University, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
  • Mohty M; EBMT Paris study office / CEREST-TC, France Department of Hematology, Saint Antoine Hospital, Paris, France INSERM UMR 938, Paris, France Université Pierre et Marie Curie, Paris, France.
Haematologica ; 101(1): e34-7, 2016 Jan.
Article en En | MEDLINE | ID: mdl-26405153

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Nucleares / Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas / Cariotipo Tipo de estudio: Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Nucleares / Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas / Cariotipo Tipo de estudio: Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2016 Tipo del documento: Article